The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment

Mizue Tanaka


We investigated the effects of the coadministration of a pump inhibitor on the efficacy of weekly risedronate treatment for osteoporosis during long-term use


Powered by

Need more features? Check out our Chrome Extension and save interactive summary cards to your Scholarcy Library.